COMMUNIQUÉS West-GlobeNewswire

Total number of shares and voting rights in Zealand Pharma at September 30, 2019
30/09/2019
Company announcement – No. 36 / 2019 Total number of shares and voting rights in Zealand Pharma at September 30, 2019 Copenhagen, September 30, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78 [...]
New Report Sheds Light on Japan’s Digital Healthcare Economy
30/09/2019
Commonalities between the UK and Japan exist, and a new whitepaper gives insights into the areas of data, digitisation and collaboration LONDON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- HIMSS, a global advisor and thought [...]
Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients
30/09/2019
– TIBSOVO ® Reduced the Risk of Disease Progression or Death by 63% (HR=0.37, p<0.001); Median PFS for Patients Randomized to TIBSOVO ® was 2.7 months Compared to 1.4 Months with Placebo – – TIBSOVO ® Patients Had 6- [...]
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer
30/09/2019
New England Journal of Medicine publishes data showing improved survival with Jevtana ® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer CARD is a treatment [...]
Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer de la prosta
30/09/2019
Le New England Journal of Medicine publie des données montrant que Jevtana ® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer [...]
Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer
30/09/2019
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in people with previously untreated advanced bladder cancer Tecentriq combination reduced the risk of disease worsening or death ( [...]
Novo Nordisk A/S – Share repurchase programme
30/09/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 30 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System
30/09/2019
AvKare Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB), is a leading distributor of healthcare products Nationwide distribution and direct sales force to more than 170 VA medical centers and government [...]
Innovation Pharmaceuticals Engages Locust Walk, A Global Life Sciences Transaction Firm
30/09/2019
Objective to further unlock market potential of pipeline and determine the appropriate path forward to enhance shareholder value Locust Walk is a global life sciences transaction firm with exceptional strategic insights [...]
Digipath to Acquire Cannabis Technology Firm VSSL Enterprises Ltd.
30/09/2019
VSSL CEO Kyle Remenda Appointed Digipath Chief Executive Officer LAS VEGAS, NV, Sept. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Digipath, Inc. (OTCQB: DIGP) , is pleased to announce it has entered into a binding [...]
Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting
30/09/2019
Presentations highlight data on odevixibat’s minimal systemic exposure and Albireo’s proprietary pruritus assessment tools BOSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage [...]
CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term
30/09/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION LONDON, Sept. 30, 2019 (GLOBE [...]
Flexion Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa
30/09/2019
BURLINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Adam Muzikant, Ph.D., Senior Vice President, Business Development, will present at the annual Cell [...]
BioNovelus, Inc. Announces Letter of Intent to Purchase Corvus Consulting, LLC
30/09/2019
POTOMAC, Md., Sept. 30, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces that it has signed a Letter of Intent (LOI) to purchase Corvus Consulting, LLC (“Corvus”). Corvus, a leading provider of scientific [...]
Executive Women In Bio Selects Chapter Leaders to Amplify Community Building and Facilitate Program Expansion for Executive Members
30/09/2019
NEW YORK, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Executive Women In Bio (EWIB) is pleased to announce a nation-wide rollout of EWIB programming content spearheaded by senior executives in biotech hubs throughout the country [...]
Transactions under Novozymes’ stock buyback program
30/09/2019
Please read the full announcement in the attached PDF Attachment 2019_38_Stock_Buybackprogram_EN
Homology Medicines to Participate in Conferences in October
30/09/2019
BEDFORD, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today presentations at the following industry, investor and scientific conferences: 2019 [...]
Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO
30/09/2019
- Clinical responses in 7 out of 12 patients with synovial sarcoma, and clinical benefit in 11 out 12 patients - PHILADELPHIA and OXFORDSHIRE, United Kingdom, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics [...]
Golden Leaf Holdings Announces California Expansion
30/09/2019
Popular Cannabis-Infused Chalice Farms Chews Product Line Launched into Largest Cannabis Market in the United States Company Partners with Leading California Co-packer and Distributor TORONTO, Sept. 30, 2019 (GLOBE [...]

Pages